Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP‐6 test
- 20 April 2006
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 64 (6) , 667-671
- https://doi.org/10.1111/j.1365-2265.2006.02525.x
Abstract
Summary: Objective Obesity is characterized by low basal levels of growth hormone (GH) and impeded GH release. However, the main problem arises in the diagnosis of GH deficiency in adults, as all accepted cut‐offs in the diagnostic tests of GH reserve are no longer valid in obese subjects. In this work, the role of obesity in the GH response elicited by the GHRH + GHRP‐6 test was assessed in a large population of obese and nonobese subjects.Patients GHRH + GHRP‐6‐induced GH peaks were evaluated in 542 subjects. One hundred and five were healthy obese, 50 were morbid obese, and 261 were nonobese (both normal weight and overweight). One hundred and seventy‐six GH‐deficient patients (obese and nonobese) were also studied.Results A regression analysis of the 366 subjects with normal pituitary function indicated that adiposity had a negative effect on the elicited GH peak (r = –0·503, P < 0·0001). A receiver operating characteristic (ROC) curve analysis showed that in subjects with a BMI 35, the currently accepted cut‐offs of the GHRH + GHRP‐6 test (GH peaks 20 µg/l: normal secretion; GH peaks 10 µg/l: GH deficiency), were fully operative. However, in subjects with a BMI > 35, normality was indicated by GH peaks 15 µg/l and GH deficiency by peaks 5 µg/l (1 µg/l = 2·6 mU/l).Conclusions This study confirms: (a) that the combined provocative test is adequate to separate normal and GH‐deficient subjects; (b) the negative effect of obesity on GH secretion; (c) that obesity accounts for 25% of the reduction of GH release; and (d) that present cut‐off values are applicable to normal weight, overweight and grade I obesity subjects, whereas in obese subjects with a BMI exceeding 35, all the normative limits of the GHRH‐GHRP +6 test must be reduced by 5 µg/l.Keywords
This publication has 34 references indexed in Scilit:
- GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adultsThe Lancet, 2000
- Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the HumanEndocrine Reviews, 1998
- Preserved Growth Hormone (GH) Secretion in Aged and Very Old Subjects after Testing with the Combined Stimulus GH-Releasing Hormone plus GH-Releasing Hexapeptide-6Journal of Clinical Endocrinology & Metabolism, 1998
- Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone DeficiencyJournal of Clinical Endocrinology & Metabolism, 1998
- Multiple Endocrine Abnormalities of the Growth Hormone and Insulin-Like Growth Factor Axis in Prepubertal Children with Exogenous Obesity: Effect of Short- and Long-Term Weight ReductionJournal of Clinical Endocrinology & Metabolism, 1997
- Is Growth Hormone Deficiency a Viable Diagnosis?Journal of Clinical Endocrinology & Metabolism, 1997
- Influence of metabolic substrates and obesity on growth hormone secretionTrends in Endocrinology & Metabolism, 1995
- Diagnosis of growth hormone deficiency in adultsThe Lancet, 1994
- Impaired Growth Hormone Responses to Growth Hormone–Releasing Factor in ObesityNew England Journal of Medicine, 1984